STF-logo-1

We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Investment Banking

A broad range of strategies, aligned for your goals

About Stifel Investment Banking

A premier investment bank with a broad set of capabilities

Stifel is a full-service investment bank with deep industry experience. We serve as strategic advisors to entrepreneurs, family-owned businesses, private equity groups, and leading public and private corporations in North America, Europe, Asia, Israel, and Latin America.

Our more than 600 investment banking professionals stand ready to provide the insight and expertise you require. Our integrated approach allows us to deliver the full capabilities of Stifel’s institutional capital markets platform and retail brokerage network, which are among the most highly regarded in the industry.

Stifel Completes Acquisition of Bryan Garnier

Learn More

Industry Coverage

Serving companies through specialized expertise and strong relationships within our core industries.

Product Coverage

Our full-service product offering and the expertise of over 700 bankers allows Stifel to provide solutions that meet all of our clients’ evolving needs.

Notable Transactions

Image
$ 175,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Mar 2025

Image
$ 202,000,000
Joint Bookrunning Manager

Initial Public Offering

Medtech

Mar 2025

Image
Advisor to Seller

Mergers & Acquisitions

Engineering & Construction, and Infrastructure

Mar 2025

Image
C$ 39,005,077
Joint Bookrunner

Private Placement

Metals & Mining

Feb 2025

Image
€ 1,320,000,000
Joint Bookrunner/Joint Lead Financial Advisor

Refinancing

Gaming & Leisure

Feb 2025

Image
A$ 80,000,000
Joint Lead Arranger & Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Feb 2025

Image
C$ 131,000,000
Advisor to Seller

Mergers & Acquisitions

Industrial & Environmental Services

Feb 2025

Image
$ 219,200,000
Joint Bookrunner

Initial Public Offering

Biopharma

Feb 2025

Image
$ 384,000,000
Joint Bookrunner

Initial Public Offering

Building Products

Feb 2025

Image
$ 150,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Feb 2025

Image
$ 230,000,000
Left Bookrunner

Follow-on Offering

Energy & Natural Resources

Feb 2025

Image
$ 75,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Jan 2025

Image
Advisor to Seller

Mergers & Acquisitions

Software

Dec 2024

Image
Advisor to Pieris

Mergers & Acquisitions

HealthTech

Dec 2024

Image
$ 50,000,000
Joint Bookrunner

Registered Direct

Biopharma

Dec 2024

Image
$ 257,600,000
Joint Bookrunner

Follow-on Offering

Biopharma

Dec 2024

Image
$ 350,000,000
Joint Bookrunner

Senior Secured Notes

Paper & Forest Products, Diversified Industries

Dec 2024

Image
$ 1,075,000,000
Joint Lead Arranger

Senior Secured Credit Facilities

Packaging, Diversified Industries

Dec 2024

Image
Advisor to Seller

Mergers & Acquisitions

HealthTech

Dec 2024

Image
Advisor to Seller

Mergers & Acquisitions

Engineering & Construction, and Infrastructure

Dec 2024

Image
$ 402,500,000
Joint Bookrunner

Follow-on Offering

Biopharma

Dec 2024

Image
$ 115,000,000
Joint Bookrunner

Confidentially Marketed Follow-on Offering

Aerospace, Defense & Government Services

Dec 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Food & Beverage

Dec 2024

Image
$ 390,000,000
Advisor to Seller

Mergers & Acquisitions

Transportation & Logistics

Dec 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Business Services

Dec 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Tech-Enabled Services

Nov 2024

Image
$ 196,956,533
Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Nov 2024

Image
Advisor to Seller

Mergers & Acquisitions

Software

Nov 2024

Image
Advisor to Seller

Mergers & Acquisitions

Restaurants

Nov 2024

Image
$ 152,500,000
Joint Bookrunner

Follow-on Offering

Aerospace, Defense & Government Services

Nov 2024

Image
$ 60,000,000
Joint Bookrunner & Joint Placement Agent

Registered Direct & PIPE

Biopharma

Nov 2024

Image
Advisor to Buyers

Mergers & Acquisitions

Food & Beverage

Nov 2024

Image
$ 610,000,000
Joint Lead Arranger

Senior Secured Credit Facilities

Food & Beverage

Nov 2024

Image
$ 900,000,000
Joint Bookrunner

Senior Secured Notes

Food & Beverage

Nov 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Biopharma

Oct 2024

Image
$ 2,200,000,000
Advisor to Buyer

Mergers & Acquisitions

Tech-Enabled Services

Oct 2024

Image
$ 2,435,000,000
Joint Lead Arranger

Senior Secured Credit Facilities

Tech-Enabled Services

Oct 2024

Image
$ 172,499,859
Joint Bookrunner

Follow-on Offering

Aerospace, Defense & Government Services

Oct 2024

Image
Sole Financial Advisor

Mergers & Acquisitions

Healthcare Services

Oct 2024

Image
Advisor to Seller

Mergers & Acquisitions

Transportation & Logistics

Sep 2024

Image
$ 94,500,000
Joint Bookrunner

Follow-on Offering

Real Estate

Sep 2024

Image
Advisor to Seller

Mergers & Acquisitions

Software

Sep 2024

Image
$ 517,500,000
Joint Bookrunner

Follow-on Offering

Industrial & Environmental Services

Sep 2024

Image
$ 150,000,000
Joint Bookrunner

Senior Notes

Energy & Natural Resources

Sep 2024

Image
$ 575,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Sep 2024

Image
$ 362,250,000
Joint Bookrunner

Initial Public Offering

Biopharma

Sep 2024

Image
$ 187,680,000
Joint Bookrunner

Initial Public Offering

Biopharma

Sep 2024

Image
$ 258,750,000
Joint Bookrunning Manager

Follow-on Offering

Biopharma

Sep 2024

Image
$ 200,536,320
Joint Placement Agent

PIPE

Biopharma

Sep 2024

Image
$ 200,000,000
Joint Bookrunner

Follow-on Offering

Biopharma

Sep 2024

Image
$ 152,173,925
Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Sep 2024

Image
Advisor to Seller

Mergers & Acquisitions

Industrial & Environmental Services

Sep 2024

Image
Lead Arranger & Administrative Agent

Senior Secured Credit Facilities

Industrial & Environmental Services, Leveraged Finance

Sep 2024

Image
$ 137,000,000

Follow-on Offering

Energy & Natural Resources

Sep 2024

Image
$ 220,000,000
Sole Bookrunner

Initial Public Offering

Business Services

Sep 2024

Image
$ 96,000,000
Joint Bookrunner

Follow-on Offering

Aerospace, Defense & Government Services

Sep 2024

Image
$ 258,750,000
Joint Bookrunner

Confidentially Marketed Follow-on Offering

Biopharma

Aug 2024

Image
$ 130,000,000
Joint Bookrunner

Registered Direct

Biopharma

Aug 2024

Image
Advisor to Seller

Mergers & Acquisitions

Engineering & Construction, and Infrastructure

Aug 2024

Image
Advisor to Seller

Mergers & Acquisitions

Healthcare, Biopharma

Aug 2024

Image
C$ 180,000,000
Left Bookrunner

Private Placement

Metals & Mining

Aug 2024

Image
Sole Placement Agent

Senior Secured Credit Facilities

Consumer Products

Aug 2024

Image
$ 100,000,000
Lead Financial Advisor

Convertible Notes & Senior Secured Term Loan

Medtech

Aug 2024

Image
$ 33,900,000
Sole Bookrunner

Follow-on Offering

Biopharma

Aug 2024

Image
$ 85,000,000
Project Gear

Advisor to Sponsor

Private Capital Advisory

2024

Image
Advisor to Seller

Mergers & Acquisition

Capital Goods

Aug 2024

Image
$ 128,000,000
Financial Advisor

SPAC Merger

Medtech

Jul 2024

Image
Advisor to Seller

Mergers & Acquisitions

Healthcare

Jul 2024

Image
C$ 20,115,000
Left Bookrunner

Follow-on Offering

Metals & Mining

Jul 2024

Image
$ 231,000,000
Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Jul 2024

Image
$ 310,000,000
Advisor to Seller

Mergers & Acquisitions

Medtech, Healthcare

Jul 2024

Image
$ 92,500,000
Advisor to Buyer

Mergers & Acquisitions

Digital Assets

Jul 2024

Image
$ 395,000,000
Advisor to Seller

Mergers & Acquisitions

Industrial Technology

Jul 2024

Image
Advisor to Seller

Mergers & Acquisitions

Biopharma

Jul 2024

Image
Advisor to Buyer

Mergers & Acquisitions

Industrial & Environmental Services

Jul 2024

Currency volume represents full credit to each underwriter. All transaction announcements appear as a matter of record only. Stifel collectively refers to Stifel, Nicolaus & Company, Incorporated and other affiliated broker-dealer subsidiaries of Stifel Financial Corp.

Leadership Team

Team

Brad Raymond

Global Co-Head of Institutional Equities and Advisory

New York

Team

Thomas B. Michaud

KBW CEO & Global Co-Head of Institutional Equities and Advisory

New York

Team

Thomas Weisel

Senior Managing Director and Director of Stifel Financial Corp.

San Francisco

Team

Dick Himelfarb

Chairman, Investment Banking and Vice Chairman, Stifel Financial Corp.

Baltimore

Team

Patrick Keeley

Vice Chairman, Investment Banking

Bethesda

Team

Michael J. Kollender

Co-Head of Investment Banking

New York

Team

Jason Stack

Co-Head of Mergers & Acquisitions

New York

Team

Seth Rubin

Head of Global Equity Capital Markets

San Francisco

Team

Carol DeNatale

Chief Operating Officer, Investment Banking

New York

Team

Chris Auld

Head of Leveraged Finance

New York

For more information, please contact Carol DeNatale at [email protected]